Autologous mesenchymal stem cell therapy (Regeneus/St Vincents Hospital Sydney)

N/A

Report date: 2023/01/12 15:47:54

Base Information

Drug NameAutologous mesenchymal stem cell therapy (Regeneus/St Vincents Hospital Sydney)
Drug Alias Name自体间充质干细胞替代疗法
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesCambium Bio LtdSt Vincent'S Hospital, Sydney
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCambium Bio LtdSt Vincent'S Hospital, Sydney
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A